FAKTOR OPTIONSSCHEIN - INCYTE CO. Stock

DE000GQ973S5

Market Closed - BOERSE MUENCHEN 02:26:08 2024-07-05 pm EDT
3.673 ^EUR	+5.73%

Current month	+31.46%
1 month	+8.12%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

S&P 500, Nasdaq Close at Record Highs After Fed Chair Powell's Comments	Jul. 02	MT
S&P 500, Nasdaq Close at Record Highs After Fed Chair Powell's Comments	Jul. 02	MT
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	Jul. 02	MT
Incyte Shares Fall Following BMO Capital Downgrade	Jul. 02	MT

More news

Quotes 5-day view

Date	Price	Change
24-07-05	3.673	+5.73%
24-07-04	3.474	+0.20%
24-07-03	3.467	+12.71%
24-07-02	3.076	+12.26%
24-07-01	2.74	-1.93%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 02:26 pm EDT

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Goldman Sachs
WKN	GQ973S
ISIN	DE000GQ973S5
Date issued	2023-11-16
Strike	69.19 $
Maturity	Unlimited
Parity	3.09 : 1
Emission price	8.49 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	10.57 €
Lowest since issue	2.139 €
Spread	0.03 €
Spread %	0.84%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.33 USD

Average target price

72.62 USD

Spread / Average Target

+26.67%

Consensus